Docs rate exhibits as better than ads

Share this article:
Physicians prefer exhibits at medical meetings to some other modes of learning about new drugs and technologies, a study suggests.

M|C Communications polled attendees at a Pri-Med meeting earlier this year—212 before and 182 after. The Healthcare Convention & Exhibitors Association presented the data in June.

Sixty-six percent favor getting information on new drugs from exhibitors, vs. 16% who prefer journal ads and 69% who prefer journal articles. For medical technology information, most clearly prefer exhibitors.

In addition, almost half said their offices restrict access by detailers or plan to within the next six months.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?